Counseling program for Black women living with HIV
Official title: A Randomized Control Trial of Striving Towards EmPowerment and Medication Adherence (STEP-AD)
Run by University of Miami · NCT06463886 · Data updated 2026-11-12
This study tests a counseling program for Black women living with HIV to see if it helps them stick to their medication and cope with trauma better than standard care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 250 (estimated) |
| Sponsor | University of Miami Academic / other |
| Locations | 1 site (Miami, Florida) |
| Status | Recruiting |
| Started | August 19, 2024 |
| Main results expected | June 1, 2029 |
| Study ends | June 1, 2029 |
| Registry record updated | October 15, 2026 |
| Trial ID | NCT06463886 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Black women aged 18 or older, living with HIV, who have a history of trauma and are currently taking antiretroviral therapy.
✕Probably not a fit
Patients with significantly interfering mental health symptoms or those unable to understand the informed consent process may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study focuses on Black women living with HIV to evaluate the effectiveness of a counseling program designed to enhance medication adherence and address trauma-related issues. Participants will receive either the STEP-AD intervention or enhanced treatment as usual (E-TAU). The study aims to empower these women by providing tailored support that acknowledges their unique experiences and challenges. The approach combines mental health support with medical adherence strategies to improve overall health outcomes.
Why it matters
Potential benefit: If successful, this program could significantly improve medication adherence and mental health outcomes for Black women living with HIV.
How similar studies have gone: Other studies have shown success in using counseling and support programs to improve health outcomes in similar populations, indicating a promising approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: 1. Black 2. Living with HIV 3. Female 4. Age 18 or older 5. English speaking 6. Viral load non-suppression (\>200 ml) within the past year OR a detectable HIV viral load (\>/= 20 within the past year) OR a lack of HIV viral load measure for 6 consecutive months or more during the past 12 months OR missed HIV care visits greater than 6 months within the past year 7. History of trauma/abuse 8. Capable of completing and fully understanding the informed consent process and study procedures Exclusion criteria: 1. Unable to completely and fully understand the informed consent process and the study procedures 2. Significantly interfering mental health symptoms (e.g., active psychosis that is untreated)
Where it's running
-
University of Miami
Miami, Florida, United States Recruiting
Study contacts
- Principal investigator: Sannisha Dale, PhD — University of Miami
- Study coordinator: Sannisha Dale, PhD
- Email: sdale@med.miami.edu
- Phone: 3052841991
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Peer-based intervention to increase PrEP use among Black sexual minority men
This study is trying to see if a community program can help Black sexual minority men in Prince George's County start and stick with PrEP to prevent HIV by reducing stigma and building support.
-
Project SHIELD 2.0: Police Education to Support Public Health in Kentucky
Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.
-
New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV
This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.
-
Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV
This program tests a peer-delivered, manualized approach to help men aged 50+ with HIV connect to LGBTQ+-affirming elder services to see if it reduces loneliness and depressive symptoms.
-
HIV vaccine test in healthy adults using CH505 nanoparticles and mRNA boosters
This early-stage study will test the safety and immune responses of CH505 vaccine regimens in healthy adults to see if they can trigger HIV-specific immune protection.
-
Stigma-reducing program to help women who use drugs stay in HIV care
This test checks whether a stigma-reduction program helps women living with HIV who use drugs stay engaged in HIV care in Ukraine.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.